Greenwich LifeSciences Inc [GLSI] stock is trading at $24.78, up 19.80%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The GLSI shares have gain 90.47% over the last week, with a monthly amount glided 196.77%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Greenwich LifeSciences Inc [NASDAQ: GLSI] stock has seen the most recent analyst activity on August 20, 2025, when Noble Capital Markets initiated its Outperform rating and assigned the stock a price target of $45. Previously, H.C. Wainwright started tracking the stock with Buy rating on September 01, 2021, and set its price target to $78.
Greenwich LifeSciences Inc [GLSI] stock has fluctuated between $7.78 and $22.31 over the past year. Greenwich LifeSciences Inc [NASDAQ: GLSI] shares were valued at $24.78 at the most recent close of the market.
Analyzing the GLSI fundamentals
Gross Profit Margin for this corporation currently stands at 0.01% with Operating Profit Margin at -5422.78%, Pretax Profit Margin comes in at -5391.94%, and Net Profit Margin reading is -5391.94%. To continue investigating profitability, this company’s Return on Assets is posted at -5.12, Equity is -10.43 and Total Capital is -8.96.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 20.03 points at the first support level, and at 15.29 for the second support level. However, for the 1st resistance point, the stock is sitting at 30.17, and for the 2nd resistance point, it is at 35.57.
Ratios To Look Out For
For context, Greenwich LifeSciences Inc’s Current Ratio is 2.35. As well, the Quick Ratio is 2.35, while the Cash Ratio is 2.35.
Transactions by insiders
Recent insider trading involved Patel Snehal, CEO and CFO, that happened on Dec 18 ’25 when 4100.0 shares were purchased. CEO and CFO, Patel Snehal completed a deal on Nov 25 ’25 to buy 4600.0 shares. Meanwhile, CEO and CFO Patel Snehal bought 10600.0 shares on Nov 07 ’25.
